LIPOSTABIL

Welcome to the Brand page for “LIPOSTABIL”, which is offered here for Pharmaceutical preparations for prevention and/or treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the respiratory system, the musculoskeletal system, the genitourinary system, for the treatment of inflammatory disorders, for use in dermatology, in oncology, for use in the gastroenterological area, and the prevention and treatment of ocular disorders or diseases; pharmaceutical preparations for prevention and/or treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the respirattory system, the musculoskeletal system, the genitourinary system, for the treatment of inflammatory disorders, for use in dermatology, in oncology, for use n the gastroenterological area, and the prevention and treatment of ocular disorders or diseases; and pharmaceuticals for the treatment of weight and fat reduction issues;providing a website on global computer networks featuring information on pharmaceutical preparations in the fields of pharmaceutical preparations for prevention and/or treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the respiratory system, the musculoskeletal system, the genitourinary system, for the treatment of inflammatory disorders, for use in dermatology, in oncology, for use in the gastroenterological area, and the prevention and treatment of ocular disorders or diseases; pharmaceutical preparations for prevention and/or treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the respirattory system, the musculoskeletal system, the genitourinary system, for the treatment of inflammatory disorders, for use in dermatology, in oncology, for use n the gastroenterological area, and the prevention and treatment of ocular disorders or diseases; and pharmaceuticals for the treatment of weight and fat reduction issues;.

Its status is currently believed to be active. Its class is unavailable. “LIPOSTABIL” is believed to be currently owned by “A. Nattermann & Cie GmbH”.


Owner:
A. NATTERMANN & CIE GMBH
Owner Details
Description:
Pharmaceutical preparations for prevention and/or treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the respiratory system, the musculoskeletal system, the genitourinary system, for the treatment of inflammatory disorders, for use in dermatology, in oncology, for use in the gastroenterological area, and the prevention and treatment of ocular disorders or diseases; pharmaceutical preparations for prevention and/or treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the respirattory system, the musculoskeletal system, the genitourinary system, for the treatment of inflammatory disorders, for use in dermatology, in oncology, for use n the gastroenterological area, and the prevention and treatment of ocular disorders or diseases; and pharmaceuticals for the treatment of weight and fat reduction issues;providing a website on global computer networks featuring information on pharmaceutical preparations in the fields of pharmaceutical preparations for prevention and/or treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the respiratory system, the musculoskeletal system, the genitourinary system, for the treatment of inflammatory disorders, for use in dermatology, in oncology, for use in the gastroenterological area, and the prevention and treatment of ocular disorders or diseases; pharmaceutical preparations for prevention and/or treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the respirattory system, the musculoskeletal system, the genitourinary system, for the treatment of inflammatory disorders, for use in dermatology, in oncology, for use n the gastroenterological area, and the prevention and treatment of ocular disorders or diseases; and pharmaceuticals for the treatment of weight and fat reduction issues;
Categories: PHARMACEUTICAL PREPARATIONS PREVENTION OR